Employee News Online

The latest news from UNC Health Care and the UNC School of Medicine.

CAR-T therapy gives patient options after cancer returns

CAR-T therapy gives patient options after cancer returns

When Sabrina Shelton exhausted traditional treatment options, her care team at UVA referred her to UNC Lineberger’s Matthew Foster, MD, for a chimeric antigen receptor T-cell (CAR-T) therapy clinical trial. Watch the video and read the story about her journey.

CAR-T therapy gives patient options after cancer returns - Read More…